These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Halken S. Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698 [Abstract] [Full Text] [Related]
27. [Immunotherapy in allergic diseases. Evaluation of short-term efficacy of aluminum hydroxide-absorbed slow-release preparations]. Spinozzi F, Cimignoli E, Broccucci L, Gerli R, Cernetti C, Rambotti P. Clin Ter; 1991 Feb 28; 136(4):245-51. PubMed ID: 1827386 [Abstract] [Full Text] [Related]
28. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children. Caramia G, Franceschini F, Cimarelli ZA, Ciucchi MS, Gagliardini R, Ruffini E. Allerg Immunol (Paris); 1996 Nov 28; 28(9):308-10. PubMed ID: 8986246 [Abstract] [Full Text] [Related]
37. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC. Pediatr Allergy Immunol; 2006 Sep 15; 17(6):408-15. PubMed ID: 16925685 [Abstract] [Full Text] [Related]
38. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting. Marogna M, Spadolini I, Massolo A. Eur Ann Allergy Clin Immunol; 2005 Apr 15; 37(4):135-42. PubMed ID: 15916014 [Abstract] [Full Text] [Related]
40. Variations of histamine release in an atopic population. II. Clinical situation according to age and duration of immunotherapy. Gamboa PM, Castillo JG, Wong E, de la Cuesta CG, Oehling A. Allergol Immunopathol (Madr); 1989 Apr 15; 17(6):279-83. PubMed ID: 2483969 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]